Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.

Volume 31, Number 1—January 2025
Research Letter

Replication Restriction of Influenza A(H5N1) Clade 2.3.4.4b Viruses by Human Immune Factor, 2023–2024

Jakob Ankerhold1, Susanne Kessler1, Martin Beer, Martin Schwemmle, and Kevin CiminskiComments to Author 
Author affiliation: University of Freiburg Spemann Graduate School of Biology and Medicine, Freiburg, Germany (J. Ankerhold); University Medical Centre and Faculty of Medicine Freiburg, Freiburg (J. Ankerhold, S. Kessler, M. Schwemmle, K. Ciminski); Friedrich-Loeffler-Institut, Greifswald–Insel Riems, Germany (M. Beer)

Main Article

Figure 1

In vitro testing of replication of mammalian influenza A(H5N1) clade 2.3.4.4b isolates against human MxA. MDCK cells overexpressing MxA (MDCK-MxA) or antivirally inactive MxAT103A (MDCK-MxAT103A) were infected with an influenza A isolate at a multiplicity of infection of 0.001; viral titers were determined at the indicated time points. A) Pandemic H1N1. B) KAN-1 H5N1. C) White mink H5N1. D) Blue fox H5N1. E) Cat H5N1. F) Bovine H5N1. Data are mean ± SD of n = 3 independent experiments. Dashed line indicates detection limit. hpi, hours postinfection; MxA, human myxovirus resistance protein 1.

Figure 1. In vitro testing of replication of mammalian influenza A(H5N1) clade 2.3.4.4b isolates against human MxA. MDCK cells overexpressing MxA (MDCK-MxA) or antivirally inactive MxAT103A (MDCK-MxAT103A) were infected with an influenza A isolate at a multiplicity of infection of 0.001; viral titers were determined at the indicated time points. A) Pandemic H1N1. B) KAN-1 H5N1. C) White mink H5N1. D) Blue fox H5N1. E) Cat H5N1. F) Bovine H5N1. Data are mean ± SD of n = 3 independent experiments. Dashed line indicates detection limit. hpi, hours postinfection; MxA, human myxovirus resistance protein 1.

Main Article

1These first authors contributed equally to this article.

Page created: December 04, 2024
Page updated: December 22, 2024
Page reviewed: December 22, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external